In the battle against Coronavirus,”the progress made in the private sector stands in stark contrast to the how the public sector has found innovation and entrepreneurialism so difficult”, writes the IEA’s Director-General Mark Littlewood.

In his column for The Times, Mark argues that the story of how, and how quickly, two pharmaceutical companies – Biontech and Pfizer – have achieved such a breakthrough, shows how the profit-making private sector should be embraced, rather than shunned, when it comes to improving the health of our citizens.

Read the full article here.